Select Medical
SEM was delisted on the 30th of June, 2026.
271 hedge funds and large institutions have $1.99B invested in Select Medical in 2024 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 33 increasing their positions, 190 reducing their positions, and 61 closing their positions.
1,233% more call options, than puts
Call options by funds: $200K | Put options by funds: $15K
5% less funds holding
Funds holding: 286 → 271 (-15)
21% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 61
43% less capital invested
Capital invested by funds: $3.46B → $1.99B (-$1.47B)
60.33% less ownership
Funds ownership: 141.82% → 81.49% (-60%)
83% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 190
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$28.6M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$21.4M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$14.4M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$9.69M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$8.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$290M |
| 2 |
BlackRock
New York
|
-$234M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$205M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$139M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$74.1M |
SEM Hedge Fund Activity: Q4 2024 in Review
271 of the 7,602 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q4 2024, worth a combined $1.99B — down 43% from $3.46B a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of SEM and 48 opened new positions — a net loss of 13 holders — while 190 trimmed existing stakes and 33 added.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $28.6M. The largest seller was T. Rowe Price Associates, cutting an estimated $290M.
- 271 institutional investors held Select Medical (SEM) as of Q4 2024, down from 286 in Q3 2024.
- Funds reported $1.99B of Select Medical stock for Q4 2024, down 43% quarter-over-quarter.
- 48 funds opened new Select Medical positions in Q4 2024 and 61 closed out, a net change of -13 holders.
- The largest Select Medical buyer in Q4 2024 was Manulife (Manufacturers Life Insurance), an estimated $28.6M added.
- The largest Select Medical seller in Q4 2024 was T. Rowe Price Associates, an estimated $290M sold.
Based on aggregated 13F filings for Q4 2024.